NewGenIvf Group Ltd (NIVF) News & EventsNIVFNewGenIvf Group Ltd

NewGenIvf Group Prices Public Offering at $1.25M

NewGenIvf Group announced the pricing of a public offering made on a reasonable best efforts basis with gross proceeds to the company expected to be approximately $1.25M, before deducting placement agent fees and other offering expenses payable by the company. The offering consists of 17,857,143 Ordinary Shares or Pre-Funded Warrants in lieu thereof. The public offering price per Common Share is 7c, or 6.999c for each Pre-Funded Warrant, which is equal to the public offering price per Ordinary Share to be sold in the offering minus an exercise price of $0.00001 per Pre-Funded Warrant. Aggregate gross proceeds to the company are expected to be approximately $1.25M. The transaction is expected to close on or about September 30, 2026, subject to the satisfaction of customary closing conditions. Aegis Capital Corp. is acting as the exclusive placement agent for the offering.

NewGenIvf Group Ltd Trading Halted, News Pending

NewGenIvf Group Ltd trading halted, news pending